PPD

$35.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.29 (-0.81%) As of 3:22 PM UTC today

Why Robinhood?

You can buy or sell PPD and other stocks, options, and ETFs commission-free!

About PPD

PPD, Inc. provides drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The firm also provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations and other industry participants. Its clinical development services include all phases of development (Phase I-IV), peri- and post-approval and site and patient access services; laboratory services offers advanced testing services, including bioanalytical, biomarker, vaccine, good manufacturing practice and central laboratory services. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. The listed name for PPD is PPD, Inc. Common Stock.

CEO
David S. Simmons
Employees
23,000
Headquarters
Wilmington, North Carolina
Founded
1985
Market Cap
12.68B
Price-Earnings Ratio
235.24
Dividend Yield
Average Volume
740.80K
High Today
$36.06
Low Today
$35.55
Open Price
$35.92
Volume
69.57K
52 Week High
$37.51
52 Week Low
$10.61

Collections

PPD Earnings

$0.00
$0.11
$0.22
$0.33
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 3, After Hours

You May Also Like

TPVY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure